BRAINLIFE.ORG




Current Neuro-Oncology




Volume 4 Number 5
31 May 2002




Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 5, 31 May






Steinbok P, Hentschel S, Almqvist P, Cochrane DD, Poskitt K.
Management of optic chiasmatic/hypothalamic astrocytomas in children.
Can J Neurol Sci. 2002 May;29(2):132-8. PMID: 12035834. Observational study.
ˍ




Twelves C, Campone M, Coudert B, Van den Bent M, de Jonge M, Dittrich C, Rampling R, Sorio R, Lacombe D, de Balincourt C, Fumoleau P; European Organisation for Research and Treatment of Cancer-Early Clinical Studies Group/New Drug Development Programme.
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme.
Ann Oncol. 2002 May;13(5):777-80. doi: 10.1093/annonc/mdf121. PMID: 12075748. Interventional study. ˍ




Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P, Kaur B, Van Meir EG.
Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Cancer Res. 2002 May 1;62(10):2897-905. PMID: 12019170. Case report.
ˍ




Johannesen TB, Rasmussen K, Winther FØ, Halvorsen U, Lote K.
Late radiation effects on hearing, vestibular function, and taste in brain tumor patients.
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):86-90. doi: 10.1016/s0360-3016(01)02810-3. PMID: 12007945. Observational study.
ˍ




Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A, Thomas G, Gutmann DH, Giovannini M.
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.
Genes Dev. 2002 May 1;16(9):1060-5
. doi: 10.1101/gad.226302. PMID: 12000789. Laboratory investigation. ˍ




Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH.
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):58-66. doi: 10.1016/s0360-3016(01)02819-x. PMID: 12007942.
Interventional study. ˍ




Quinn JA, Pluda J, Dolan ME, Delaney S, Kaplan R, Rich JN, Friedman AH, Reardon DA, Sampson JH, Colvin OM, Haglund MM, Pegg AE, Moschel RC, McLendon RE, Provenzale JM, Gururangan S, Tourt-Uhlig S, Herndon JE 2nd, Bigner DD, Friedman HS.
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
J Clin Oncol. 2002 May 1;20(9):2277-83. doi: 10.1200/JCO.2002.09.084. PMID: 11980998.
Interventional study. ˍ




Saran FH, Baumert BG, Khoo VS, Adams EJ, Garré ML, Warrington AP, Brada M.
Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood.
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):43-51. doi: 10.1016/s0360-3016(02)02734-7. PMID: 12007940. Observational study.
ˍ




Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R.
Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
J Clin Oncol. 2002 May 1;20(9):2267-76. doi: 10.1200/JCO.2002.09.126. PMID: 11980997. Interventional study. ˍ




Simon JM, Cornu P, Boisserie G, Hasboun D, Tep B, Hardiman C, Valery CA, Delattre JY, Dormont D, Baillet F, Mazeron JJ.
Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):67-74. doi: 10.1016/s0360-3016(01)02804-8. PMID: 12007943. Observational study. ˍ